Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01279044 · ClinicalTrials.gov registry record · Phase 1
Reducing HIV Risk Among Episodic Substance Using Men Who Have Sex With Men (SUMSM)
A Phase 1 study of HIV Infections and Episodic Substance Use, sponsored by San Francisco Department of Public Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 385
- Enrollment target
- 1
- Study location
NCT01279044: Completed Phase 1 study of HIV Infections and Episodic Substance Use, sponsored by San Francisco Department of Public Health.
NCT01279044 is a Phase 1 study of HIV Infections and Episodic Substance Use that has completed, run by San Francisco Department of Public Health. The registered enrollment target is 385 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (13% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01279044, a Phase 1 study of HIV Infections and Episodic Substance Use, has completed, sponsored by San Francisco Department of Public Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 385 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if persons randomized to receive adapted Personalized Cognitive Risk-reduction Counseling (PCC) will report greater reductions in unprotected anal sex behavior compared with persons who do not receive Personalized Cognitive Risk-reduction Counseling (PCC).
Primary Outcome
The outcome measure data shows the rate of change in the mean value in the number of total unprotected anal intercourse events over time. Behaviors were self-reported at each study visit using "during the past 3 months" as the recall period. Study visits took place at baseline, 3 month, and 6 month timepoints.
Conditions Studied
Interventions
- BEHAVIORAL Adapted Personalized Cognitive Risk-reduction Counseling intervention (PCC)
- BEHAVIORAL Standard HIV testing with information only
Study Locations (1)
California
- San Francisco Department of Public Health, AIDS Office - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2007-09 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
What the finished NCT01279044 record still lists
NCT01279044 is an interventional study that assigns participants to a tested intervention. The registered 385 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (13% lower).
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Adapted Personalized Cognitive Risk-reduction Counseling intervention (PCC) is the first listed.
NCT01279044 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01279044 about?
NCT01279044 is a clinical study titled "Reducing HIV Risk Among Episodic Substance Using Men Who Have Sex With Men (SUMSM)". The purpose of this study is to determine if persons randomized to receive adapted Personalized Cognitive Risk-reduction Counseling (PCC) will report greater reductions in unprotected anal sex behavior compared with persons who do not receive Personalized Cognitive Risk-reduction Counseling (PCC).
What is the current status of trial NCT01279044?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 385 participants. The study started on 2007-09. Estimated completion is 2012-11.
What conditions does trial NCT01279044 study?
This clinical trial studies the following conditions: HIV Infections, Episodic Substance Use.
What interventions are being tested in trial NCT01279044?
The interventions under investigation include: Adapted Personalized Cognitive Risk-reduction Counseling intervention (PCC) (BEHAVIORAL), Standard HIV testing with information only (BEHAVIORAL).
Who is sponsoring clinical trial NCT01279044?
This trial is sponsored by San Francisco Department of Public Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01279044 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01279044's enrollment target sits among peer trials
385 87th of 542 higher than 456 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
RECRUITING · Phase 1
-
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
RECRUITING · Phase 1
-
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
RECRUITING · Phase 1
-
First Time in Human Study of Long Acting VH4524184 Formulations
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05373823 · 385 participants · NA
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
- NCT05503173 · 385 participants · NA
Telehealth for Pain and Unhealthy Drinking Among PLWH
- NCT06226883 · 385 participants · Phase 2
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- NCT06290063 · 385 participants · Phase 2
Cannabidiol and Older Adult Cannabis Users
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia